Received Aug 1, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARCEL | VARICELLA (VARIVAX) | MERCK & CO. INC. | UNK | Z004454 | OT |
| VARCEL | VARICELLA (VARIVAX) | MERCK & CO. INC. | UNK | — | OT |
No additional AE; VARIVAX involved in temperature excursion has been administered; This spontaneous report was received from a Medical Assistant and refers to a non-pregnant 45-year-old female patient. The patient's medical history, concurrent conditions and concomitant therapies were not reported. On 09-Jul-2025, the patient was vaccinated with Varicella Virus Vaccine Live (Oka-Merck) (VARIVAX), (lot #Z004454, expiration date: 13-Feb-2027) 1 dose. The vaccine was reconstituted with sterile diluent (MERCK STERILE DILUENT) (lot # and expiration date were not reported) administered by Unknown route for prophylaxis. The vaccine Varicella Virus Vaccine Live (Oka-Merck) (VARIVAX) was involved in temperature excursion of 36.5F during a time frame of 2 hours 21 minutes 0 seconds. There was no previous temperature excursion. No patient symptoms had been reported. This is one of several cases from the same source.